Physiologic role of the complement system in host defense, disease, and malnutrition

Nutrition

Volumn 14, Issue 4, 1998, Pages 391-398

  Sakamoto, Motoko ^a   Fujisawa, Yumiko ^a   Nishioka, Kusuya ^b  

^a WAYO WOMEN'S UNIVERSITY   (Japan)

^b Viral Hepatitis Foundation of Japan   (Japan)

Author keywords

Acquired immunity; Complement system; Host defense; Hypocomplementemia; Innate immunity; Malnutrition

Indexed keywords

COMPLEMENT SYSTEM; HOST RESISTANCE; HUMAN; HYPOCOMPLEMENTEMIA; INFECTION; INFECTION RESISTANCE; INFECTION RISK; MALNUTRITION; PRIORITY JOURNAL; REVIEW;

ANIMALS; C-REACTIVE PROTEIN; CARRIER PROTEINS; COLLECTINS; COMPLEMENT PATHWAY, ALTERNATIVE; COMPLEMENT SYSTEM PROTEINS; HUMANS; IMMUNITY; IMMUNOGLOBULIN M; NUTRITION DISORDERS;

ANIMALIA; BACTERIA (MICROORGANISMS);

EID: 0032054236     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(97)00473-5     Document Type: Review

References (77)

1. 1. Rapp HJ. Molecular basis of complement action. New York: Appleton-Century-Crofts. 1889
2. 2. Pascual M, French LE. Complement in human diseases: looking towards the 21st century. Immunol Today 1995;16:58
3. 3. Sakamoto M, Nishioka K. Complement system in nutritional deficiency. World Rev Nutr Diet 1992;67:114
4. 4. Nishioka K, Kawamura K, Hirayama T, et al. The complement system in tumor immunity; significance of elevated levels of complement in tumor-bearing host. Ann NY Acad Sci 1976;276:303
5. 5. Sakamoto M, Ishii S, Nishioka K, Shimada K. Complement response after experimental bacterial infection in various nutritional states. Immunology 1979;38:421
6. 6. Sakamoto M, Nishioka K, Shimada K. Effect of malnutrition and nutritional rehabilitation on tuberculin reactivity and complement level in rats. Immunology 1979;38:413
7. 7. Nishioka K, Kawamura K, Kawashima T, Shimada K, Kogure M. C3 junction of humoral and cellular factors. Proc IX Int Congr Allergy Ser 1979;414:230
8. 8. Sakamoto M. The sequence of recovery of the complement systems and phytohemagglutinin skin reactivity in malnutrition. Nutr Res 1982;2:137
9. 9. Muller-Eberhard HJ, Miescher PA. Complement. Berlin: Springer-Verlag, 1985
10. 10. Fujii A. Studies on the bactericidal action of fresh normal serum Ii. Role of divalent cations in hemolytic and bactericidal action of the normal serum. Jpn J Hygiene 1955;10:131
11. 11. Nishioka K. Intramolecular C3 cascade: interaction between C3 and cellular components in biophylaxis network. Igaku No Ayumi 1986; 136:903
12. 12. Sakamoto M, Ishii S, Nishioka K, Shimada K. Level of complement activity and components C1, C4, C2 and C3 in complement response to bacterial challenge in malnourished rats. Infect Immun 1981;32:553
13. 13. Sakamoto M, Ishii S, Nishioka K. Heightened resistance against Listeria monocytogenes infection in malnourished rats after lentinan treatment correlation with C3 levels. Nutr Res 1983;3:705
14. 14. Kawanobe Y, Sakamoto M, Nishioka K. C3Bi formation at the time of complement enhancement in malnourished rats. Nutr Res 1988;8: 1277
15. 15. Fearon DT, Locksley RM. The instructive role of innate immunity in the acquired immune response. Science 1996;272:50
16. 16. Henson P. A complement to host defense. Nature 1996;383:25
17. 17. Nishioka K, Linscott WD. Component of guinea pig complement. I. Separation of a serum fraction essential for immune hemolysis and immune adherence. J Exp Med 1963;118:767
18. 18. Pillemer L, Blum L, Lepow IH, et al. The properdin system and immunity I. Demonstration and isolation of a new serum protein, properdin and its role in immune phenomena. Science 1954;120: 279
19. 19. Ginsburg HS, Horsfall FL Jr. A labile component of normal serum which combines with various viruses. Neutralization of infectivity and inhibition of hemagglutination by the component. J Exp Med 1949; 90:475
20. 20. Takagi T. Inactivation of ED virus by fresh mouse serum and studies on the nature of properdin. Jpn J Hygiene 1959;14:299
21. 21. Kawasaki T, Eton R, Yamashina I. Isolation and characterization of a mannose-binding protein from rabbit liver. Biochem Biophys Res Commun 1978;81:1018
22. 22. Turner MW. Mannose binding protein. Biochemical Society Transactions 1993;22:88
23. 23. Kawakami M, Ihara I, Ihara S, Suzuki A, Fukui K. A group of bactericidal factors conserved by vertebrates for more than 300 million years. J Immunol 1984;132:2578
24. 24. Kawakami M, Ihara I, Suzuki A, Harada Y. Properties of a new complement-dependent bactericidal factor specific for Ra chemotype salmonella in sera of conventional and germ-free mice. J Immuno 1982;129:2198
25. 25. Kawasaki N, Kawasaki T, Yamashina I. A serum lectin (mannan-binding protein) has complement-dependent bactericidal activity. J Biochem 1989;106:483
26. 26. Ezekowitz RAB, Kuhlman M, Groopman JE, et al. A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus. J Exp Med 1989;169:185
27. 27. Haurum JS, Thiel S, Jones IM, et al. Complement activation upon binding of mannan-binding protein to HIV envelope glycoproteins. AIDS 1993;7:1307
28. 28. Anders EM, Hartly CA, Reading PC, et al. Complement-dependent neutralization of influenza virus by a serum mannose-binding lectin. J Gen Virol 1994;75:615
29. 29. Krizanova O, Rathova V. Serum inhibitors of myxo-virus. Curr Top Microbiol Immunol 1969;47:125
30. 30. Matsushita M, Fujita T. Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease. J Exp Med 1992;176:1497
31. 31. Thompson C. Protein proves to be a key link in innate immunity. Science 1995;269:301
32. 32. Holmskov U, Malhotra R, Sim RB, et al. Collectins: collagenous C-type lectins of the innate immune defense system. Immunol Today 1994;15:67
33. 33. Jensenius JC. MBP and innate immunity. Science 1995;270:1104
34. 34. Kuhlman M, Joiner K, Ezekowitz RAB. The human mannose protein functions as an opsonin. J Exp Med 1989;169:1733
35. 35. Malhotra R, Thiel S, Reid KB, Sim RB. Human leukocyte C1q receptor binds other soluble proteins with collagen domains. J Exp Med 1990;172:955
36. 36. Steel DM, Whitehead AS. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 1994;15:81
37. 37. Baumann H, Gauldie J. The acute phase response. Immunol Today 1994;15:74
38. 38. Wu X, Okada N, Iwamori M, Okada H. Ig M natural antibody against an asialo-oligosaccharide, gangliotetraose (Gg4), sensitizes HIV-1 infected cells for cytolysis by homologous complement. Int J Immunol 1996;8:153
39. 39. Jones PC, Sze LL, Morton DL, Irie RF. Prolonged survival for melanoma patients with elevated IgM antibody to oncofetal antigen. J Natl Cancer Inst 1980;66:249
40. 40. Mayer MM. Complement and complement fixation. In: Kabat EA, Mayer MM, eds. Experimental immunochemistry, 2nd ed. Springfield: Charles C. Thomas Publishing, 1961:133
41. 41. Matsumoto M, Seya T. Homologous C3 depositional and homotypic cell adhesion in a human myeloid cell line. Eur J Immunol 1993;23: 2270
42. 42. Matsumoto M, Yamashita F, Iida K, Tomita M, Seya T. Purification and characterization of a human membrane protein that activates the alternative complement pathway and allows the deposition of homologous complement C3. J Exp Med 1995;181:115
43. 43. Matsui M, Tsuji S, Nishimura H, Nagasawa S. Activation of the alternative pathway of complement by apoptotic Jurkat cells. FEBS Lett 1994;351:419
44. 44. Tsuji S, Kaji K, Nagasawa S. Activation of the alternative pathway of human complement by apoptotic human umbilical vein endothelial cells. J Biochem 1994;116:794.
45. 45. Mold C, Nemerow GR, Bradt BM, Cooper NR. CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cells. J Immunol 1988;140: 1923
46. 46. Chandra RK. Serum complement and immunoconglutinin in malnutrition. Arch Dis Child 1975;50:225
47. 47. Sirisinha S, Suskind R, Edelman R, Charupatana CH, Olson RE. Complement and C3-proactivator levels in children with protein-calorie malnutrition and effect of dietary treatment. Lancet 1973;1: 1016
48. 48. Haller L, Zubler RH, Lambert PH. Plasma levels of complement components and complement haemolytic activity in protein-energy malnutrition. Clin Exp Immunol 1978;34:248
49. 49. Inada Y, Kamiyama M, Kanemitsu T, et al. In vivo binding of circulating immune complexes by C3b receptors (CR1) of transfused erythrocytes. Ann Rheumatic Dis 1989;48:287
50. 50. Weisman HF, Bartow T, Leppo MK, et al. Soluble human complement receptor type 1: in vivo inhibitor or complement suppressing post-ischemic myocardial inflammation and necrosis. Science 1990; 249:146
51. 51. Morgan BP. Complement regulator molecules: application to therapy and transplantation. Immunol Today 1995;16:257
52. 52. Schur PH, Sandson J. Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med 1968;278:533
53. 53. Lloyd W, Schur PH. Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). Medicine 1981;60:208
54. 54. Brouet JC, Klauvel JP, Danon F, Kelin M, Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med 1974;57:775
55. 55. Zeiss CR, Burch FX, Marder RJ, et al. A hypocomplementemic vasculitic urticarial syndrome. Report of four new cases and definition of the disease. Am J Med 1980;68:867
56. 56. Abel T, Andrews BS, Cunningham PH, et al. Rheumatoid vasculitis: effect of cyclophosphamide on the clinical course and levels of circulating immune complexes. Ann Int Med 1980;93:407
57. 57. West CD. The complement profile in clinical medicine. Complement Inflammation 1989;6:49
58. 58. Kaenhy WD, Ozawa T, Schwarz MI, et al. Acute nephritis and pulmonary alveolitis following pneumococcal pneumonia. Arch Intern Med 1978;138:806
59. 59. Jordan SC, Buckingham B, Sakai R, Olson D. Sudies of immune-complex glomerulonephritis mediated by human thyroglobulin. N Engl J Med 1981;304:1212
60. 60. Varga L, Clas F, Fust G, et al. Patients with CLL and hypocomplementaemia have an impaired serum bactericidal activity against the Salmonella minnesota mutant. Complement 1988;5:40
61. 61. Gonzalo A, Mampaso F, Gallego N, et al. Hemolytic uremic syndrome with hypocomplementemia and deposits of IgM and C3 in the involved renal tissue. Clin Nephrol 1981;16:193
62. 62. Monnens J, Molenaar J, Lambert PH, Prosemans W, van Munster P. The complement system in hemolytic-uremic syndrome in childhood. Clin Nephrol 1980;13:168
63. 63. Anonymous. Editorial. Haemolytic-uraemic syndrome in childhood. Lancet 1978;1:26
64. 64. Barre P, Kaplan BS, de Chadarevian JP, Drummond KH. Hemolytic uremic syndrome with hypocomplementemia serum C3NeF, and glomerular deposits of C3. Arch Pathol Lab Med 1977;101:357
65. 65. Levin J, Poore E, Young NS, et al. Gram-negative sepsis: detection of endotoxemia with the limulus test. Ann Int Med 1972;76:1
66. 66. Pocidalo MA, Gibert C, Verroust P, et al. Circulating immune complexes and severe sepsis: duration of infection as the main determinant. Clin Exp Immunol 1982;47:513
67. 67. Pfueller SL, Firkin BG, De Rosbo NK, Riglar A, MacKay IR. Association of increased immune complexes, platelet IgG and serum IgG in chronic active hepatitis. Clin Exp Immunol 1983;54:655
68. 68. Goldstein IM, Cala K, Radin AR, et al. Evidence of complement catabolism in acute pancreatitis. Am J Med Sci 1978;275:257
69. 69. Schur PH. Inherited complement component abnormalities. Ann Rev Med 1986;37:333
70. 70. Frank MM. Complement in the pathophysiology of human disease. N Engl J Med 1987;316:1525
71. 71. Thompson RA, Winterborn MH. Hypocomplementaemia due to a genetic deficiency of BIH globulin. Clin Exp Immunol 1981;46:110
72. 72. Gelfand JA, Donelan M, Hawiger A, Burke JF. Alternative complement pathway activation increases mortality in a model of burn injury in mice. J Clin Invest 1982;70:1170
73. 73. Pinciard RN, Olson MS, Giclas PC, et al. Consumption of classical complement components by heat subcellular membranes in vitro and in patients after acute myocardial infarction. J Clin Invest 1975;56:740
74. 74. Hakin RM, Fearon DT, Lazarus JM. Biocompatibility of dialysis membranes: effects of chronic complement activation. Kidney Int 1984;26:194
75. 75. Phanuphak P, Hanvanich M, Sakulramrung R, et al. Complement changes in falciparum malaria infection. Clin Exp Immunol 1985;59: 571
76. 76. Kapadia A, Gupta S, Good RA, Day NK. Familial herpes simplex infection associated with activation of the complement system. Am J Med 1979;67:122
77. 77. Lim HW, Pohl-Fitzpatrick MB, Gigli I. Activation of the complement system in patients with porphyrias and irradiation in vivo. J Clin Invest 1984;74:1961